266 related articles for article (PubMed ID: 8848553)
21. [Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis].
Sabatier J; Ibarrola D; Malet-Martino M; Berry I
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):858-62. PubMed ID: 11677409
[TBL] [Abstract][Full Text] [Related]
22. [Blood volume changes after the radiotherapy of the central nervous system].
Wenz F; Fuss M; Scholdei R; Essig M; Lohr F; Rempp K; Brix G; Knopp MV; Engenhart R; Wannenmacher M
Strahlenther Onkol; 1996 Oct; 172(10):559-66. PubMed ID: 8966673
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
[TBL] [Abstract][Full Text] [Related]
24. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
25. [Magnetic resonance tomography of intracranial tumors: use of contrast media versus T2-weighted tomograms].
Schörner W; Laniado M; Claussen C; Kazner E; Niendorf HP; Felix R
Rofo; 1986 Mar; 144(3):315-22. PubMed ID: 3008234
[TBL] [Abstract][Full Text] [Related]
26. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.
Chawla S; Zhang Y; Wang S; Chaudhary S; Chou C; O'Rourke DM; Vossough A; Melhem ER; Poptani H
J Comput Assist Tomogr; 2010; 34(6):836-41. PubMed ID: 21084897
[TBL] [Abstract][Full Text] [Related]
27. [Metabolic imaging of human brain tumors: H-1 chemical shift imaging and PET].
Koga M; Yoshikawa K; Obata T; Mizoe J; Tsujii H; Ikehira H; Shishido F
Nihon Rinsho; 1997 Jul; 55(7):1774-8. PubMed ID: 9233025
[TBL] [Abstract][Full Text] [Related]
28. [Spectroscopic imaging of the brain. Examination technique and clinical applications].
Heindel W; Kugel H; Lanfermann H; Landwehr P; Krahe T; Lackner K
Nervenarzt; 1995 Dec; 66(12):895-900. PubMed ID: 8584073
[TBL] [Abstract][Full Text] [Related]
29. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo.
Usenius T; Usenius JP; Tenhunen M; Vainio P; Johansson R; Soimakallio S; Kauppinen R
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):719-24. PubMed ID: 7558964
[TBL] [Abstract][Full Text] [Related]
30. Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging.
Bizzi A; Movsas B; Tedeschi G; Phillips CL; Okunieff P; Alger JR; Di Chiro G
Radiology; 1995 Jan; 194(1):271-6. PubMed ID: 7997566
[TBL] [Abstract][Full Text] [Related]
31. [MRI and MRS in the diagnosis of cancer].
Itai Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):639-45. PubMed ID: 2539787
[TBL] [Abstract][Full Text] [Related]
32. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy.
Chinn RJ; Wilkinson ID; Hall-Craggs MA; Paley MN; Miller RF; Kendall BE; Newman SP; Harrison MJ
Radiology; 1995 Dec; 197(3):649-54. PubMed ID: 7480733
[TBL] [Abstract][Full Text] [Related]
33. Localized brain proton MRS metabolic patterns in HIV-related encephalopathies.
Vion-Dury J; Confort-Gouny S; Nicoli F; Dhiver C; Gastaut JA; Gastaut JL; Cozzone PJ
C R Acad Sci III; 1994 Sep; 317(9):833-40. PubMed ID: 7882165
[TBL] [Abstract][Full Text] [Related]
34. Response to article "Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors".
Sijens PE
Acta Radiol; 2010 Apr; 51(3):326-8. PubMed ID: 20192894
[No Abstract] [Full Text] [Related]
35. Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast.
Sijens PE; Vecht CJ; Levendag PC; van Dijk P; Oudkerk M
Invest Radiol; 1995 Dec; 30(12):738-44. PubMed ID: 8748188
[TBL] [Abstract][Full Text] [Related]
36. [Utility of proton magnetic resonance spectroscopy in the diagnosis of human brain tumors].
Yoshida Y; Yoshioka Y
No Shinkei Geka; 1991 May; 19(5):421-7. PubMed ID: 1852248
[TBL] [Abstract][Full Text] [Related]
37. MR spectroscopy for differentiation of recurrent glioma from radiation-induced changes.
Goenka AH; Kumar A; Sharma R
AJR Am J Roentgenol; 2009 Dec; 193(6):W569-70. PubMed ID: 19933634
[No Abstract] [Full Text] [Related]
38. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
Bruhn H; Frahm J; Gyngell ML; Merboldt KD; Hänicke W; Sauter R; Hamburger C
Radiology; 1989 Aug; 172(2):541-8. PubMed ID: 2748837
[TBL] [Abstract][Full Text] [Related]
40. Short echo time proton MR spectroscopic imaging.
Posse S; Schuknecht B; Smith ME; van Zijl PC; Herschkowitz N; Moonen CT
J Comput Assist Tomogr; 1993; 17(1):1-14. PubMed ID: 8380426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
